Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide

Br J Ophthalmol. 1997 Feb;81(2):130-2. doi: 10.1136/bjo.81.2.130.

Abstract

Background: Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.

Methods: Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.

Results: All patients recovered excellent visual acuity.

Conclusion: Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antirheumatic Agents / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Injections, Intravenous
  • Lupus Erythematosus, Systemic / complications*
  • Middle Aged
  • Optic Atrophy / drug therapy*
  • Optic Atrophy / etiology
  • Visual Acuity / drug effects

Substances

  • Antirheumatic Agents
  • Glucocorticoids
  • Cyclophosphamide